|
‘Patient
diary cards and compliance charts can be considered
as source documents’
|
Monoclonal
antibodies: An overview
Unlike chemotherapy and radiotherapy, which act in a
less specific way, the aim of monoclonal antibody treatment
is to destroy cancerous cells in a targeted way and
to leave other types of cells unharmed, say C V R Srikant
and Gogri Gaurav
|
|
Editorial
Policing IPR
boundaries
Edit Article
Approval
of generic drugs
|
National pharmacovigilance
programme: Monitoring drug safety
The pharmacovigilance programme initiated by Drugs Control
Department, Government of India, promises to maintain
a close watch over the use of drugs and their effects
on people, says Dr Sampada Patvardhan
|
|
Industry-academia
interactions: Bridging the gap
One important way of facilitating interaction between
academia and industry is for teachers to take sabbatical
at business organisations in their field of expertise.
Such involvement will facilitate mutual understanding
of each other’s strengths and challenges, say Alka
Ahuja, Sanjula Baboota, Javed Ali and R K Khar
|
‘Exporters
registered with Pharmexcil can avail several benefits’
Last month, Pharmexcil was vested with the powers to process
and issue Registration-cum-Membership Certificate (RCMC).
Dr P V Appaji, executive director, Pharmexcil, in an interview
with Satyapal Menon, speaks about the role of the council
on the issuance of RCMCs and various advantages for its
members. |
